These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15701764)

  • 1. Impact of topiramate on serum bicarbonate concentrations in adults.
    Garris SS; Oles KS
    Ann Pharmacother; 2005 Mar; 39(3):424-6. PubMed ID: 15701764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between topiramate use and serum bicarbonate levels in a veteran population.
    Sciegienka A; Argo T; Cantrell M; Alexander B
    Ann Pharmacother; 2015 Jun; 49(6):670-3. PubMed ID: 25829486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate and metabolic acidosis in pediatric epilepsy.
    Takeoka M; Holmes GL; Thiele E; Bourgeois BF; Helmers SL; Duffy FH; Riviello JJ
    Epilepsia; 2001 Mar; 42(3):387-92. PubMed ID: 11442157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy.
    Takeoka M; Riviello JJ; Pfeifer H; Thiele EA
    Epilepsia; 2002 Sep; 43(9):1072-5. PubMed ID: 12199733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate and metabolic acidosis: a case series and review of the literature.
    Groeper K; McCann ME
    Paediatr Anaesth; 2005 Feb; 15(2):167-70. PubMed ID: 15675937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate and metabolic acidosis in infants and toddlers.
    Philippi H; Boor R; Reitter B
    Epilepsia; 2002 Jul; 43(7):744-7. PubMed ID: 12102678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic impact of topiramate on acid-base balance and potassium in childhood.
    Belotti EA; Taddeo I; Ragazzi M; Pifferini R; Simonetti GD; Bianchetti MG; Ramelli GP
    Eur J Paediatr Neurol; 2010 Sep; 14(5):445-8. PubMed ID: 20005754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate-induced metabolic acidosis: report of two cases.
    Ko CH; Kong CK
    Dev Med Child Neurol; 2001 Oct; 43(10):701-4. PubMed ID: 11665828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
    Knudsen JF; Sokol GH; Flowers CM
    J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topiramate in monotherapy or in combination as a cause of metabolic acidosis in adults with epilepsy].
    Ruiz-Granados VJ; Márquez-Romero JM
    Rev Neurol; 2015 Feb; 60(4):159-63. PubMed ID: 25670045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.
    Mirza NS; Alfirevic A; Jorgensen A; Marson AG; Pirmohamed M
    Pharmacogenet Genomics; 2011 May; 21(5):297-302. PubMed ID: 21278619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic acidosis due to topiramate.
    Prescrire Int; 2004 Oct; 13(73):186. PubMed ID: 15499701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and stone-risk profiles with topiramate treatment.
    Welch BJ; Graybeal D; Moe OW; Maalouf NM; Sakhaee K
    Am J Kidney Dis; 2006 Oct; 48(4):555-63. PubMed ID: 16997051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate: new indication. Single-agent therapy in refractory epilepsy: for a few patients only.
    Prescrire Int; 2004 Oct; 13(73):165-7. PubMed ID: 15499695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposition to metabolic acidosis induced by topiramate.
    Montenegro MA; Guerreiro MM; Scotoni AE; Guerreiro CA
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1021-4. PubMed ID: 11105067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperventilation and cerebrospinal fluid acidosis caused by topiramate.
    Montcriol A; Meaudre E; Kenane N; Asencio Y; Bordes J; Palmier B
    Ann Pharmacother; 2008 Apr; 42(4):584-7. PubMed ID: 18420530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
    Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
    Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.